Back to top
more

Oramed Pharmaceuticals Inc. (ORMP)

(Delayed Data from NSDQ)

$23.82 USD

23.82
934,761

+1.13 (4.98%)

Updated Sep 27, 2021 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.60%
2Buy19.21%
3Hold10.85%
4Sell6.62%
5Strong Sell3.32%
S&P50011.33%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (215 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Brokerage Reports

0 items in cart

INDUSTRY: Medical - Products

Reports for Purchase

Showing records 1 - 20 ( 11474 total )

Industry: Medical - Products

Record: 1

09/27/2021

Daily Note

Pages: 2

MORNING OUTLOOK

Provider: M Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Agios Pharmaceuticals, Inc.

Industry: Medical - Products

Record: 2

09/27/2021

Company Report

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Neogen Corporation

Industry: Medical - Products

Record: 3

09/27/2021

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 4

09/27/2021

Company Report

Pages: 10

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Agios Pharmaceuticals, Inc.

Industry: Medical - Products

Record: 5

09/24/2021

Industry Report

Pages: 54

Details cannot be displayed until the posted date of availability

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 100.00

Available: 10/09/2021

Research Provided by a Third Party

Company: Senestech, Inc.

Industry: Medical - Products

Record: 6

09/24/2021

Daily Note

Pages: 4

Details cannot be displayed until the posted date of availability

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Available: 10/04/2021

Research Provided by a Third Party

Company: Omeros Corporation

Industry: Medical - Products

Record: 7

09/24/2021

Industry Report

Pages: 15

Details cannot be displayed until the posted date of availability

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 50.00

Available: 10/09/2021

Research Provided by a Third Party

Company: BioRad Laboratories, Inc.

Industry: Medical - Products

Record: 8

09/24/2021

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Senestech, Inc.

Industry: Medical - Products

Record: 9

09/23/2021

Company Report

Pages: 4

Details cannot be displayed until the posted date of availability

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Available: 10/03/2021

Research Provided by a Third Party

Company: NuVasive, Inc.

Industry: Medical - Products

Record: 10

09/23/2021

Company Report

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Cardiovascular Systems, Inc.

Industry: Medical - Products

Record: 11

09/23/2021

Company Report

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Veru Inc.

Industry: Medical - Products

Record: 12

09/21/2021

Company Report

Pages: 5

Details cannot be displayed until the posted date of availability

Provider: H.C. Wainwright & Co., Inc.

Analyst: CHEN Y

Price: 10.00

Available: 10/21/2021

Research Provided by a Third Party

Company: Veru Inc.

Industry: Medical - Products

Record: 13

09/21/2021

Industry Report

Pages: 4

Details cannot be displayed until the posted date of availability

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 10.00

Available: 10/01/2021

Research Provided by a Third Party

Company: Lonza Group Ag

Industry: Medical - Products

Record: 14

09/21/2021

Daily Note

Pages: 7

Details cannot be displayed until the posted date of availability

Provider: KeyBanc Capital Markets/McDonald

Analyst: Research Department

Price: 25.00

Available: 12/20/2021

Research Provided by a Third Party

Company: Eagle Pharmaceuticals, Inc.

Industry: Medical - Products

Record: 15

09/21/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for EGRX

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Omeros Corporation

Industry: Medical - Products

Record: 16

09/21/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for OMER

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Perrigo Company plc

Industry: Medical - Products

Record: 17

09/21/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for PRGO

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Insulet Corporation

Industry: Medical - Products

Record: 18

09/21/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for PODD

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Meridian Bioscience Inc.

Industry: Medical - Products

Record: 19

09/21/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for VIVO

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cardiovascular Systems, Inc.

Industry: Medical - Products

Record: 20

09/21/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for CSII

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party